Related Experiment Video

Updated: Jul 3, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Post-translational regulation of the tumor suppressor p27(KIP1)

J Vervoorts1, B Lüscher

  • 1Institute of Biochemistry, Medical School, RWTH Aachen University, Pauwelsstrasse 30, 52057, Aachen, Germany. jvervoorts-weber@ukaachen.de

Cellular and Molecular Life Sciences : CMLS
|July 19, 2008
PubMed

Insights

Cyclin-dependent kinase (CDK) inhibitors like p27(KIP1) regulate cell division and can act as tumor suppressors. Understanding p27(KIP1) regulation is key to developing cancer therapies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Cell division is controlled by cyclin/cyclin-dependent kinase (CDK) complexes, requiring precise regulation.
  • CDK inhibitors, such as p27(KIP1), are crucial regulators of cell cycle progression and are implicated in diseases.
  • p27(KIP1) exhibits tumor suppressor activity but also influences other cellular processes, including cell motility.

Purpose of the Study:

  • To elucidate the multifaceted roles and regulatory mechanisms of p27(KIP1) in cellular processes.
  • To investigate how p27(KIP1) integrates extracellular and intracellular signals to control cell cycle progression.
  • To determine the potential anti- or pro-tumorigenic activities of different p27(KIP1) isoforms.

Main Methods:

  • Analysis of cyclin/CDK complex regulation.
  • Investigation of p27(KIP1) as a CDK inhibitor.
  • Exploration of p27(KIP1)'s non-CDK related functions, such as cell motility.
  • Study of phosphorylation sites and associated signal transduction pathways regulating p27(KIP1).

Main Results:

  • p27(KIP1) is a key regulator of CDK activity throughout the cell cycle.
  • p27(KIP1) possesses tumor suppressor functions.
  • p27(KIP1) also modulates cell motility, with some activities potentially promoting oncogenesis.
  • Multiple phosphorylation sites on p27(KIP1) are targeted by various signaling pathways.

Conclusions:

  • Understanding p27(KIP1) regulation is vital for discerning its dual role in tumorigenesis.
  • Identifying specific p27(KIP1) isoforms and their functions may offer prognostic value in cancer.
  • Knowledge of p27(KIP1) regulation could reveal novel therapeutic strategies for cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...